Reuters logo
5 个月前
BRIEF-Oncosec Medical says entered into technology access program agreement with Inhibrx
2017年3月14日 / 上午10点18分 / 5 个月前

BRIEF-Oncosec Medical says entered into technology access program agreement with Inhibrx

March 14 (Reuters) - Oncosec Medical Inc

* Oncosec medical inc says entered into a technology access program (tap) agreement with inhibrx, lp

* Oncosec medical- inhibrx will use co's proprietary gene delivery technologies; genesis research generator, proprietary applicators Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below